Citation Impact
Citing Papers
Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes
2019 Science
Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis
2017
Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: A Long March to Therapeutic Successes
2016
The role of brain vasculature in neurodegenerative disorders
2018
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
The Discovery and Development of Liraglutide and Semaglutide
2019
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases
2017
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
2017
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Obesity as a risk factor for Alzheimer's disease: weighing the evidence
2017
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
2018
Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans
2016
Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta‐analysis
2018
Works of Michael Gejl being referenced
In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
2016
Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes
2012
Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
2017
Influence of GLP-1 on Myocardial Glucose Metabolism in Healthy Men during Normo- or Hypoglycemia
2014
Risk of cardiovascular disease: The effects of diabetes and anti-diabetic drugs — A nested case–control study
2014
Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease
2017
Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer´s disease - protocol for a controlled, randomized double-blinded trial.
2012
The Niels Lassen Award Session and Oral Sessions
2017